Share Twitter LinkedIn Facebook Email Chuck Wiseman, MD, BriaCell Therapeutics, talks about Rollover Protocol Approval Bria-IMT in combination with a checkpoint inhibitor at Annual Meeting 2018.
Strategizing Personalized Breast Cancer Treatment: A Promising Overview of Advances and Clinical Applications [39 SLIDES] Breast 4 Mins Read
Fertility Preservation: Interrupting endocrine therapy to attempt pregnancy in Breast Cancer Breast 2 Mins Read